Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• BrayFFerlayJSoerjomataramIGLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin2018201868394424
   Google Scholar
• FerlayJColombetMIGlobal and regional estimates of the incidence and mortality for 38 cancers: GLOBOCAN 2018LyonInternational Agency for Research on Cancer/World Health Organization2018
   Google Scholar
• LiFMWangXQIdentifying anticancer peptides by using improved hybrid compositionsSci Rep201663391027670968
   PubMedGoogle Scholar
• ZhengPPLiJKrosJMBreakthroughs in modern cancer therapy and elusive cardiotoxicity: critical research-practice gaps, challenges, and insightsMed Res Rev201838132537628862319
   PubMedGoogle Scholar
• WuQYangZNieYShiYFanDMulti-drug resistance in cancer chemotherapeutics: mechanisms and lab approachesCancer Lett2014347215916624657660
   PubMed Web of Science ®Google Scholar
• LiSZhangBJiangDWeiYZhangNHerb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulaeBMC Bioinformatics201011S11S6
   PubMedGoogle Scholar
• HeathJRNanotechnologies for biomedical Science and translational medicineProc Natl Acad Sci U S A201511247144361444326598663
   PubMed Web of Science ®Google Scholar
• HoBNPfefferCMSinghATUpdate on Nanotechnology-based drug delivery systems in cancer treatmentAnticancer Res201737115975598129061776
   PubMedGoogle Scholar
• WangKKievitFMZhangMNanoparticles for cancer gene therapy: recent advances, challenges, and strategiesPharmacol Res2016114566627771464
   PubMedGoogle Scholar
• YangYYuCAdvances in silica based nanoparticles for targeted cancer therapyNanomedicine201612231733226706409
   PubMed Web of Science ®Google Scholar
• GroverJKYadavSPPharmacological actions and potential uses of Momordica charantia: a reviewJ Ethnopharmacol200493112313215182917
   PubMed Web of Science ®Google Scholar
• CyranoskiDWhy Chinese medicine is heading for clinics around the worldNature2018561772444845030258149
   PubMedGoogle Scholar
• AnandPSundaramCJhuraniSKunnumakkaraABAggarwalBBCurcumin and cancer: an “old-age” disease with an “age-old” solutionCancer Lett2008267113316418462866
   PubMed Web of Science ®Google Scholar
• DuvoixABlasiusRDelhalleSChemopreventive and therapeutic effects of curcuminCancer Lett2005223218119015896452
   PubMed Web of Science ®Google Scholar
• ZhangTDChenGQWangZGWangZYChenSJChenZArsenic trioxide, a therapeutic agent for APLOncogene200120497146715311704843
   PubMed Web of Science ®Google Scholar
• DograSBandiSViswanathanPGuptaSArsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinomaCancer Lett20153562 Pt B95396125444910
   PubMedGoogle Scholar
• JiHLiYJiangFInhibition of transforming growth factor beta/ SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancerCancer Sci2014105121541154925283513
   PubMedGoogle Scholar
• WangXJiangFMuJArsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491Toxicol Lett20142272758324680928
   PubMedGoogle Scholar
• JiangXChenCZhaoWZhangZSodium arsenite and arsenic tri-oxide differently affect the oxidative stress, genotoxicity and apoptosis in A549 cells: an implication for the paradoxical mechanismEnviron Toxicol Pharmacol201336389190224004876
   PubMedGoogle Scholar
• WalkerAMStevensJJNdebeleKTchounwouPBEvaluation of arsenic trioxide potential for lung cancer treatment: assessment of apoptotic mechanisms and oxidative damageJ Cancer Sci Ther2016080119
   Google Scholar
• AlkhalafMJaffalSPotent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: novel cellular mechanisms involving the ERKs/p53 cascadeFree Radic Biol Med200641231832516814113
   PubMedGoogle Scholar
• ZhuWQinWZhangKTrans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancerNutr Cancer201264339340022332908
   PubMed Web of Science ®Google Scholar
• PatelKRBrownVAJonesDJClinical pharmacology of resveratrol and its metabolites in colorectal cancer patientsCancer Res201070197392739920841478
   PubMed Web of Science ®Google Scholar
• RaufAImranMButtMSNadeemMPetersDGMubarakMSResveratrol as an anti-cancer agent: a reviewCrit Rev Food Sci Nutr20185891428144728001084
   PubMed Web of Science ®Google Scholar
• CaiHScottEKholghiACancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and miceSci Transl Med20157298298ra117
   PubMedGoogle Scholar
• OiNYuanJMalakhovaMResveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1Oncogene201534202660267124998844
   PubMedGoogle Scholar
• ZouMWangJGaoJHanHFangYPhosphoproteomic analysis of the antitumor effects of ginsenoside Rg3 in human breast cancer cellsOncol Lett20181532889289829435015
   PubMedGoogle Scholar
• YangXZouJCaiHGinsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signalingBiomed Pharmacother2017961240124529169725
   PubMedGoogle Scholar
• LiuTZhaoLHouHDingLChenWLiXGinsenoside 20(S)-Rg3 suppresses ovarian cancer migration via hypoxia-inducible factor 1 alpha and nuclear factor-kappa B signalsTumour Biol2017395101042831769222
   Google Scholar
• SuMQZhouYRRaoXBaicalein induces the apoptosis of HCT116 human colon cancer cells via the upregulation of DEPP/ Gadd45a and activation of MAPKsInt J Oncol201853275076029749481
   PubMed Web of Science ®Google Scholar
• SongLChenXWangPGaoSQuCLiuLEffects of baicalein on pancreatic cancer stem cells via modulation of sonic hedgehog pathwayActa Biochim Biophys Sin201850658659629697746
   PubMedGoogle Scholar
• ChaoJISuWCLiuH-FBaicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AktMol Cancer Ther20076113039304818025287
   PubMed Web of Science ®Google Scholar
• ZhouQWangSZhangHThe combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cellsActa Pharmacol Sin200930121648165819960010
   PubMed Web of Science ®Google Scholar
• YanXIRuiXZhangKAIBaicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathwayOncol Rep201533273774325502212
   PubMed Web of Science ®Google Scholar
• WangYFLiTTangZHBaicalein triggers autophagy and inhibits the protein kinase B/Mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cellsPhytother Res201529567467925641124
   PubMed Web of Science ®Google Scholar
• WuJYTsaiKWLiYZAnti-Bladder-Tumor effect of baicalein from Scutellaria baicalensis Georgi and its application in vivoEvid Based Complement Alternat Med2013201357975123573134
   PubMed Web of Science ®Google Scholar
• GuoZHuXXingZBaicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathwayMol Cell Biochem20154061–211111925957503
   PubMedGoogle Scholar
• PengYGuoCYangYBaicalein induces apoptosis of human cervical cancer HeLa cells in vitroMol Med Rep20151132129213425373554
   PubMed Web of Science ®Google Scholar
• ChandrashekarNSelvamaniASubramanianRPandiAThiruvengadamDBaicalein inhibits pulmonary carcinogenesis-associated inflammation and interferes with COX-2, MMP-2 and MMP-9 expressions in-vivoToxicol Appl Pharmacol20122611102122369883
   PubMed Web of Science ®Google Scholar
• YuJGuoQLYouQDGambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cellsCarcinogenesis200728363263817012222
   PubMed Web of Science ®Google Scholar
• WangXDengRLuYGambogic acid as a non-competitive inhibitor of ATP-binding cassette transporter B1 reverses the multidrug resistance of human epithelial cancers by promoting ATP-binding cassette transporter B1 protein degradationBasic Clin Pharmacol Toxicol20131121253322759348
   PubMed Web of Science ®Google Scholar
• WuZQGuoQLYouQDZhaoLGuH-YGambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cellsBiol Pharm Bull200427111769177415516720
   PubMed Web of Science ®Google Scholar
• WangCZhangHChenYShiFChenBGambogic acid-loaded magnetic Fe(3)O(4) nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1Int J Nanomedicine2012778178722393285
   PubMed Web of Science ®Google Scholar
• GuoQLYouQDWuZQYuanSTZhaoLGeneral gambogic acids inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude miceActa Pharmacol Sin200425676977415169630
   PubMed Web of Science ®Google Scholar
• ZhuXZhangHLinYMechanisms of gambogic acid-induced apoptosis in non-small cell lung cancer cells in relation to transferrin receptorsJ Chemother200921666667220071291
   PubMed Web of Science ®Google Scholar
• NieFZhangXQiQReactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cellsToxicology20092601–3606719464570
   PubMed Web of Science ®Google Scholar
• YanFWangMChenHGambogenic acid mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cellsEur J Pharmacol20116521–3233221118682
   PubMed Web of Science ®Google Scholar
• ChenHBZhouLZMeiLGambogenic acid-induced time- and dose-dependent growth inhibition and apoptosis involving Akt pathway inactivation in U251 glioblastoma cellsJ Nat Med2012661626921879332
   PubMedGoogle Scholar
• WangKTangYSunMThe mechanism of neogambogic acid-induced apoptosis in human MCF-7 cellsActa Biochim Biophys Sin201143969870221785112
   PubMedGoogle Scholar
• MeiWDongCHuiCGambogenic acid kills lung cancer cells through aberrant autophagyPLoS One201491e8360424427275
   PubMedGoogle Scholar
• LiQChengHZhuGGambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arrestingBiol Pharm Bull201033341542020190402
   PubMed Web of Science ®Google Scholar
• ChengHSuJJPengJYGambogenic acid inhibits proliferation of A549 cells through apoptosis inducing through up-regulation of the p38 MAPK cascadeJ Asian Nat Prod Res20111311993100222007630
   PubMed Web of Science ®Google Scholar
• ZhangXXuQSaikiIQuercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expressionClin Exp Metastasis200018541542111467774
   PubMedGoogle Scholar
• TsaiPHChengCHLinC-YDietary flavonoids luteolin and quercetin suppressed cancer stem cell properties and metastatic potential of isolated prostate cancer cellsAnticancer Res201636126367638027919958
   PubMed Web of Science ®Google Scholar
• JiaLHuangSYinXZanYGuoYHanLQuercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy inductionLife Sci201820812313030025823
   PubMed Web of Science ®Google Scholar
• CalgarottoAKMasoVJuniorGCAntitumor activities of quercetin and green tea in xenografts of human leukemia HL60 cellsSci Rep201881345929472583
   PubMed Web of Science ®Google Scholar
• Anand DavidAVArulmoliRParasuramanSOverviews of biological importance of quercetin: a bioactive flavonoidPharmacogn Rev20161020848928082789
   PubMedGoogle Scholar
• LugliEFerraresiRRoatEQuercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cellsLeuk Res200933114015018774171
   PubMedGoogle Scholar
• ZhangHLiHLiuZTriptolide inhibits the proliferation and migration of medulloblastoma DAOY cells by upregulation of microRNA-138J Cell Biochem2018119129866987730156009
   PubMed Web of Science ®Google Scholar
• MaoXTongJWangYZhuZYinYWangYTriptolide exhibits antitumor effects by reversing hypermethylation of WIF1 in lung cancer cellsMol Med Rep20181833041304930015908
   PubMed Web of Science ®Google Scholar
• ZhouZLYangYXDingJLiYCMiaoZ-HTriptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanismsNat Prod Rep201229445747522270059
   PubMed Web of Science ®Google Scholar
• LiSGShiQWYuanLYC-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cellsJ Exp Clin Cancer Res2018375129523159
   PubMed Web of Science ®Google Scholar
• WangYLiuTLiHEnhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancerJ Biomater Sci Polym Ed201627754555626786618
   PubMed Web of Science ®Google Scholar
• HuGGongXWangLTriptolide promotes the clearance of α-synuclein by enhancing autophagy in neuronal cellsMol Neurobiol20175432361237226957304
   PubMedGoogle Scholar
• KimSHKangJGKimCSSynergistic cytotoxicity of BIIB021 with triptolide through suppression of PI3K/AKT/mTOR and NF-κB signal pathways in thyroid carcinoma cellsBiomed Pharmacother201683223227470546
   PubMedGoogle Scholar
• LiWYangYHuZLingSFangMNeuroprotective effects of DAHP and triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activationFront Neuroanat201594825954164
   PubMed Web of Science ®Google Scholar
• YaoZWanYLiBBerberine induces mitochondrialmediated apoptosis and protective autophagy in human malignant pleural mesothelioma NCIH2452 cellsOncol Rep20184063603361030272347
   PubMedGoogle Scholar
• FukudaKHibiyaYMutohMKoshijiMAkaoSFujiwaraHInhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cellsJ Ethnopharmacol199966222723310433483
   PubMed Web of Science ®Google Scholar
• WangZWangY-SChangZ-MBerberine-loaded Janus nanocarriers for magnetic field-enhanced therapy against hepatocellular carcinomaChem Biol Drug Des201789346446927618577
   PubMed Web of Science ®Google Scholar
• KuoHPChuangTCYehMHGrowth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/AKT signaling pathwayJ Agric Food Chem201159158216822421699261
   PubMed Web of Science ®Google Scholar
• KimSHanJLeeSKBerberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cellsJ Surg Res20121761e21e2922381172
   PubMedGoogle Scholar
• LinCCYangJSChenJTBerberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathwayAnticancer Res2007275A3371337817970083
   PubMedGoogle Scholar
• MantenaSKSharmaSDKatiyarSKBerberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARPCarcinogenesis200627102018202716621886
   PubMedGoogle Scholar
• ShinDSKimHNShinKDCryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cellsCancer Res200969119320219118003
   PubMed Web of Science ®Google Scholar
• ChenWLuoYLiuLCryptotanshinone inhibits cancer cell proliferation by suppressing mammalian target of rapamycin-mediated cyclin D1 expression and RB phosphorylationCancer Prev Res20103810151025
   PubMed Web of Science ®Google Scholar
• ChenLWangHJXieWYaoYZhangYSWangHCryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivoMol Med Rep2014962447245224682389
   PubMed Web of Science ®Google Scholar
• XiaoWZhuMXZhuMXPanXJYangZHZhouS-YInhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasisInt J Oncol20124062029203722344367
   PubMedGoogle Scholar
• WangYFuQZhaoWTetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivoMol Med Rep20138498498823912183
   PubMedGoogle Scholar
• WangSJGaoYChenHDihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivoCancer Lett201029319910820137856
   PubMed Web of Science ®Google Scholar
• JiYZhangYCPeiLBShiLLYanJLMaXHAnti-tumor effects of dihydroartemisinin on human osteosarcomaMol Cell Biochem20113511–29910821234653
   PubMedGoogle Scholar
• GaoXLuoZXiangTWangKLiJWangPDihydroartemisinin induces endoplasmic reticulum stress-mediated apoptosis in HepG2 human hepatoma cellsTumori201197677178022322845
   PubMedGoogle Scholar
• LaiHSinghNPSelective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrinCancer Lett199591141467750093
   PubMed Web of Science ®Google Scholar
• LaiHSasakiTSinghNPMessayAEffects of artemisinin-tagged holotransferrin on cancer cellsLife Sci200576111267127915642597
   PubMedGoogle Scholar
• ChenHGuSDaiHLiXZhangZDihydroartemisinin sensitizes human lung adenocarcinoma A549 cells to arsenic trioxide via apoptosisBiol Trace Elem Res2017179220321228261759
   PubMedGoogle Scholar
• OhMChoiYHChoiSAnti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cellsInt J Oncol199914586987510200336
   PubMedGoogle Scholar
• NakataHKikuchiYTodeTInhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cellsJpn J Cancer Res19988977337409738980
   PubMedGoogle Scholar
• XieXEberdingAMaderaCRh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer modelsJ Urol200617551926193116600800
   PubMed Web of Science ®Google Scholar
• XiaTWangYNZhouCXGinsenoside Rh2 and Rg3 inhibit cell proliferation and induce apoptosis by increasing mitochondrial reactive oxygen species in human leukemia Jurkat cellsMol Med Rep20171563591359828440403
   PubMedGoogle Scholar
• YangJYuanDXingTGinsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinaseJ Ginseng Res201640440040827746693
   PubMed Web of Science ®Google Scholar
• YangZZhaoTLiuHZhangLGinsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagySci Rep2016611938326783250
   PubMedGoogle Scholar
• HuangJPengKWangLGinsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathwayActa Biochim Biophys Sin201648875075527177748
   PubMedGoogle Scholar
• LiSGaoYMaWEGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2Tumor Biol201435655935598
   PubMedGoogle Scholar
• HanSJeongAJYangHGinsenoside 20(S)-Rh2 exerts anticancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cellsJ Ethnopharmacol2016194839027566200
   PubMedGoogle Scholar
• GuanNHuoXZhangZZhangSLuoJGuoWGinsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13Tumor Biol201536967896795
   PubMedGoogle Scholar
• AbedinpourPBaronVTChrastinaAPlumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: a pre-clinical studyProstate201777161550156228971491
   PubMedGoogle Scholar
• KawiakADomachowskaAPlumbagin suppresses the invasion of HER2-overexpressing breast cancer cells through inhibition of IKKα-Mediated NF-κB activationPLoS One20161110e016406427727280
   PubMedGoogle Scholar
• OhTIYunJMParkEJPlumbagin suppresses α-MSH-Induced melanogenesis in B16F10 mouse melanoma cells by inhibiting tyrosinase activityInt J Mol Sci2017182320
   PubMedGoogle Scholar
• LiuYCaiYHeCChenMLiHAnticancer properties and pharmaceutical applications of plumbagin: a reviewAm J Chin Med201745342344128359198
   PubMedGoogle Scholar
• PanSTLiZLHeZXQiuJXZhouS-FMolecular mechanisms for tumour resistance to chemotherapyClin Exp Pharmacol Physiol201643872373727097837
   PubMed Web of Science ®Google Scholar
• CronaDJFasoANishijimaTFMcgrawKAGalskyMDMilowskyMIA systematic review of strategies to prevent cisplatin-induced nephrotoxicityOncologist201722560961928438887
   PubMed Web of Science ®Google Scholar
• ZhuJCarozziVAReedNEthoxyquin provides neuroprotection against cisplatin-induced neurotoxicitySci Rep2016612886127350330
   PubMedGoogle Scholar
• KarasawaTSteygerPSAn integrated view of cisplatin-induced nephrotoxicity and ototoxicityToxicol Lett2015237321922726101797
   PubMed Web of Science ®Google Scholar
• HuSLiXXuRThe synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cellsActa Biochim Biophys Sin201648652853527084520
   PubMedGoogle Scholar
• GaoLPLiZGuoZYZhaoY-MThe effects of vitamin C on DDP-induced anemia in ratsToxicol Mech Methods201323638338823343350
   PubMed Web of Science ®Google Scholar
• LuDYChenEHWuHYAnticancer drug combinations, how far we can go through?Anticancer Agents Med Chem2017171212827039923
   PubMedGoogle Scholar
• WebsterRMCombination therapies in oncologyNat Rev Drug Discov2016152818226837588
   PubMedGoogle Scholar
• ZhangWShiHChenCCurcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loopPhytomedicine201848516130195880
   PubMedGoogle Scholar
• MohapatraPSatapathySRSiddharthSDasDNayakAKunduCNResveratrol and curcumin synergistically induces apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21(Waf1/Cip1) mediated inhibition of Hh-Gli signalingInt J Biochem Cell Biol201566758426212257
   PubMed Web of Science ®Google Scholar
• XiaCBaiXHouXCryptotanshinone reverses cisplatin resistance of human lung carcinoma A549 cells through down-regulating Nrf2 pathwayCell Physiol Biochem201537281682426356271
   PubMedGoogle Scholar
• LiCJChuCYHuangLHSynergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivoCancer Lett2012319220321322306340
   PubMedGoogle Scholar
• CheJBLiuZHMaHBInfluence of As2O3 combined with ginsenosides Rg3 on inhibition of lung cancer NCI-H1299 cells and on subsistence of nude mice bearing hepatomaAsian Pac J Trop Med201471077277525129458
   PubMedGoogle Scholar
• YuanZJiangHZhuXLiuXLiJGinsenoside Rg3 promotes cytotoxicity of paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancerBiomed Pharmacother20178922723228231544
   PubMed Web of Science ®Google Scholar
• ChangLHuoBLvYWangYLiuWGinsenoside Rg3 enhances the inhibitory effects of chemotherapy on esophageal squamous cell carcinoma in miceMol Clin Oncol2014261043104625279195
   PubMedGoogle Scholar
• TangQJiFSunWCombination of baicalein and 10-hydroxy camptothecin exerts remarkable synergetic anti-cancer effectsPhytomedicine201623141778178627912880
   PubMedGoogle Scholar
• ZhenYSAnticancer Drug research and developmentBeijing, ChinaChemical Industry Press2004
   Google Scholar
• ZhanYChenYLiuRZhangHZhangYPotentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signalingArch Pharm Res20143781086109524318305
   PubMed Web of Science ®Google Scholar
• LiuNHuangHXuLThe combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivoToxicol Lett2014224333334024291039
   PubMed Web of Science ®Google Scholar
• MajumdarAPBanerjeeSNautiyalJCurcumin synergizes with resveratrol to inhibit colon cancerNutr Cancer200961454455319838927
   PubMed Web of Science ®Google Scholar
• MasuelliLMarzocchellaLFocaccettiCResveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosisFront Biosci2012171498508
   Google Scholar
• SánchezYSimónGPCalviñoEde BlasEAllerPCurcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell linesJ Pharmacol Exp Ther2010335111412320605902
   PubMedGoogle Scholar
• FehlDJAhmedMCurcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancersVirus Res2017228142327865863
   PubMedGoogle Scholar
• ZhangJYLinMTZhouMJCombinational treatment of cur-cumin and quercetin against gastric cancer MGC-803 cells in vitroMolecules2015206115241153426111180
   PubMed Web of Science ®Google Scholar
• LiYFengLLiYJiangWShanNWangXArtesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxideLeuk Lymphoma20145561366137223906016
   PubMed Web of Science ®Google Scholar
• TomuleasaCSoritauOFischer-FodorEArsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinomaHematol Oncol Stem Cell Ther201142606621727766
   PubMedGoogle Scholar
• WangWQinSKChenBAChenHYExperimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinomaWorld J Gastroenterol20017570270511819858
   PubMedGoogle Scholar
• ZhaoYYYuLLiuBLHeXJZhangB-YDownregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell linesMol Med Rep20151257335734326459009
   PubMed Web of Science ®Google Scholar
• YuQChenBZhangXQianWYeBZhouYArsenic trioxide-enhanced, matrine-induced apoptosis in multiple myeloma cell linesPlanta Med2013790977578123700110
   PubMedGoogle Scholar
• RaiGMishraSSumanSShuklaYResveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: a mechanistic insightPhytomedicine201623323324226969377
   PubMedGoogle Scholar
• JiangQYangMQuZZhouJZhangQResveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cellsBMC Complement Altern Med201717147728978315
   PubMedGoogle Scholar
• KongFZhangRZhaoXZhengGWangZWangPResveratrol raises in vitro anticancer effects of paclitaxel in NSCLC cell line A549 through COX-2 expressionKorean J Physiol Pharmacol201721546547428883751
   PubMedGoogle Scholar
• YuanYXueXGuoRBSunXLHuGResveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathwayCNS Neurosci Ther201218753654622530672
   PubMed Web of Science ®Google Scholar
• Tomas-HernándezSBlancoJRojasCResveratrol potently counteracts quercetin starvation-induced autophagy and sensitizes HepG2 cancer cells to apoptosisMol Nutr Food Res20186251700610
   Google Scholar
• ZhaoXYYangSChenYRLiPCDouMMZhangJResveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivoPLoS One201496e9892524901647
   PubMedGoogle Scholar
• KimSMLeeSYYukDYInhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxelArch Pharm Res200932575576519471891
   PubMed Web of Science ®Google Scholar
• PanQXueMXiaoS-SWanY-JXuD-BA combination therapy with baicalein and taxol promotes mitochondria-mediated cell apoptosis: involving in Akt/β-Catenin signaling pathwayDNA Cell Biol2016351164665627414207
   PubMedGoogle Scholar
• WangLHLiYYangSNGambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signallingBr J Cancer2014110234135224300974
   PubMed Web of Science ®Google Scholar
• XiaGWangHSongZMengQHuangXHuangXGambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)J Exp Clin Cancer Res201736110728797284
   PubMedGoogle Scholar
• JiangXLZhangYLuoCLWuXHTargeting renal cell carcinoma with gambogic acid in combination with sunitinib in vitro and in vivoAsian Pac J Cancer Prev201213126463646823464475
   PubMedGoogle Scholar
• HeYDingJLinYGambogenic acid alters chemosensitivity of breast cancer cells to adriamycinBMC Complement Altern Med201515118126066793
   PubMedGoogle Scholar
• ChenRZhangHLiuPWuXChenBGambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myelomaJ Cancer20178583985128382147
   PubMedGoogle Scholar
• MaZSHuynhTHNgCPDoPTNguyenTHHuynhHReduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferationInt J Oncol20042451297130415067354
   PubMed Web of Science ®Google Scholar
• SunSGongFLiuPMiaoQMetformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/ PI3K/Akt signaling pathwayGene2018664505729678660
   PubMed Web of Science ®Google Scholar
• ChanSTChuangCHLinYCLiaoJWLiiCKYehS-LQuercetin enhances the antitumor effect of trichostatin A and suppresses muscle wasting in tumor-bearing miceFood Funct20189287187929292417
   PubMedGoogle Scholar
• TangQJiFWangJGuoLLiYBaoYQuercetin exerts synergetic anti-cancer activity with 10-hydroxy camptothecinEur J Pharm Sci201710922323228822757
   PubMed Web of Science ®Google Scholar
• LeiCSHouYCPaiMHLinMTYehS-LEffects of quercetin combined with anticancer drugs on metastasis-associated factors of gastric cancer cells: in vitro and in vivo studiesJ Nutr Biochem20185110511329125991
   PubMed Web of Science ®Google Scholar
• AlsaiedOASangwanVBanerjeeSSorafenib and triptolide as combination therapy for hepatocellular carcinomaSurgery2014156227027924953273
   PubMedGoogle Scholar
• MatsuiYWatanabeJIkegawaMKamotoTOgawaONishiyamaHCancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53Oncogene200827334603461418391982
   PubMedGoogle Scholar
• LiuYXiaoEYuanLLiGTriptolide Synergistically Enhances Antitumor Activity of Oxaliplatin in Colon Carcinoma In Vitro and In VivoDNA Cell Biol201433741842524720675
   PubMedGoogle Scholar
• TangXYZhuYQTaoWHWeiBLinXLSynergistic effect of triptolide combined with 5-fluorouracil on colon carcinomaPostgrad Med J20078397933834317488865
   PubMedGoogle Scholar
• QiaoZHeMHeMUSynergistic antitumor activity of gemcitabine combined with triptolide in pancreatic cancer cellsOncol Lett20161153527353327123146
   PubMed Web of Science ®Google Scholar
• PanYZhangFZhaoYBerberine enhances chemosensitivity and induces apoptosis through Dose-orchestrated AMPK signaling in breast cancerJ Cancer2017891679168928775788
   PubMed Web of Science ®Google Scholar
• ZhuTLiLLXiaoGFBerberine increases doxorubicin sensitivity by suppressing STAT3 in lung cancerAm J Chin Med20154371487150226503561
   PubMedGoogle Scholar
• DuJSunYLuYYBerberine and evodiamine act synergistically against human breast cancer MCF-7 cells by inducing cell cycle arrest and apoptosisAnticancer Res201737116141615129061795
   PubMedGoogle Scholar
• RenKZhangWWuGSynergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cellsBiomed Pharmacother2016841748175927876206
   PubMed Web of Science ®Google Scholar
• WenCWuLFuLZhangXZhouHBerberine enhances the anti-tumor activity of tamoxifen in drugsensitive MCF7 and drugresistant MCF7/TAM cellsMol Med Rep20161432250225627432642
   PubMedGoogle Scholar
• HuangYWangKGuCBerberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenibOncol Rep20184031525153230015938
   PubMed Web of Science ®Google Scholar
• WangCJWangCHanJEffect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancerMol Biol Rep201340126579658524135803
   PubMedGoogle Scholar
• ZouXLiangJSunJAllicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathwayJ Pharmacol Sci2016131423324027177453
   PubMed Web of Science ®Google Scholar
• DaiBMaYWangWDihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI-H460 cells by repressing MAP kinase pathways and inflammatory mediatorsJ Cell Mol Med201721102573258528444871
   PubMedGoogle Scholar
• LiuYBiTWangZOxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/ Akt/mTOR pathwayApoptosis201621121398140727671687
   PubMedGoogle Scholar
• SongMQZhuJSChenJLSynergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cellsWorld J Gastroenterol200713121788179317465467
   PubMedGoogle Scholar
• ByunJMJeongDHLeeDSTetraarsenic oxide and cisplatin induce apoptotic synergism in cervical cancerOncol Rep20132941540154623338680
   PubMed Web of Science ®Google Scholar
• TangJHZhangHMZhangZHZhangX-LEffect of tetramethylpyrazine combined with cisplatin on VEGF, KLF4 and ADAMTS1 in Lewis lung cancer miceAsian Pac J Trop Med201710881381828942831
   PubMedGoogle Scholar
• Castillo-PichardoLDharmawardhaneSFGrape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancerNutr Cancer20126471058106923061908
   PubMed Web of Science ®Google Scholar
• StearnsMEAmatangeloMDVarmaDSellCGoodyearSMCombination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency miceAm J Pathol201017763169317920971741
   PubMed Web of Science ®Google Scholar
• LiangGTangALinXGreen tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancerInt J Oncol201037111112320514403
   PubMed Web of Science ®Google Scholar
• BrodskyFMMonoclonal antibodies as magic bulletsPharm Res198805119
   Google Scholar
• YeBLRuanXJZhengZHCaiHJChitosan-coated doxorubicin nanoparticles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathwayBiochem Biophys Res Commun2018495141442029097204
   PubMedGoogle Scholar
• GaoGHLiYLeeDSEnvironmental pH-sensitive polymeric micelles for cancer diagnosis and targeted therapyJ Control Release2013169318018423195533
   PubMed Web of Science ®Google Scholar
• ZhangXAchaziKSteinhilberDKratzFDerneddeJHaagRA facile approach for dual-responsive prodrug nanogels based on den-dritic polyglycerols with minimal leachingJ Control Release201417420921624225227
   PubMed Web of Science ®Google Scholar
• ZhangHWangKZhangPHeWSongALuanYRedox-sensitive micelles assembled from amphiphilic mPEG-PCL-SS-DTX conjugates for the delivery of docetaxelColloids Surf B Biointerfaces2016142899726938324
   PubMed Web of Science ®Google Scholar
• SunYWXuJZhouJLiuW-JTargeted drugs for systemic therapy of lung cancer with brain metastasesOncotarget2018945459547229435193
   PubMedGoogle Scholar
• WickMRMetastases of malignant neoplasms: Historical, biological, & clinical considerationsSemin Diagn Pathol201835211212229198586
   PubMed Web of Science ®Google Scholar
• ObinuAGaviniERassuGMaestriMBonferoniMCGiunchediPLymph node metastases: importance of detection and treatment strategiesExpert Opin Drug Deliv201815545946729504430
   PubMed Web of Science ®Google Scholar
• HullLCFarrellDGrodzinskiPHighlights of recent developments and trends in cancer nanotechnology research – View from NCI Alliance for nanotechnology in cancerBiotechnol Adv201432466667823948249
   PubMedGoogle Scholar
• YallapuMMKhanSMaherDMAnti-cancer activity of cur-cumin loaded nanoparticles in prostate cancerBiomaterials201435308635864825028336
   PubMed Web of Science ®Google Scholar
• ZhangZQianHYangMGambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatmentInt J Nanomedicine2017121593160528280328
   PubMed Web of Science ®Google Scholar
• ZhangYQShenYLiaoMMGalactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanismsNanomedicine2019151869730244085
   PubMed Web of Science ®Google Scholar
• Jabr-MilaneLSvan VlerkenLEYadavSAmijiMMMultifunctional nanocarriers to overcome tumor drug resistanceCancer Treat Rev200834759260218538481
   PubMed Web of Science ®Google Scholar
• NarayananSPavithranMViswanathASequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: design, synthesis, biocompatibility and pharmacokineticsActa Biomater20141052112212424389318
   PubMed Web of Science ®Google Scholar
• GowdaRKardosGSharmaASinghSRobertsonGPNanoparticle-based celecoxib and plumbagin for the synergistic treatment of melanomaMol Cancer Ther201716344045228003325
   PubMedGoogle Scholar
• TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113520304019
   PubMed Web of Science ®Google Scholar
• GaumetMVargasAGurnyRDelieFNanoparticles for drug delivery: the need for precision in reporting particle size parametersEur J Pharm Biopharm20086911917826969
   PubMed Web of Science ®Google Scholar
• YuCZhouQXiaoFEnhancing doxorubicin delivery toward tumor by hydroxyethyl Starch-g-Polylactide partner nanocarriersACS Appl Mater Interfaces2017912104811049328266842
   PubMedGoogle Scholar
• HafeezBBZhongWFischerJWPlumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse modelMol Oncol20137342843923273564
   PubMedGoogle Scholar
• LiYCHeSMHeZXPlumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cellsCancer Lett2014344223925924280585
   PubMed Web of Science ®Google Scholar
• LeeJHYeonJHKimHThe natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generationPLoS One201279e4502323028742
   PubMed Web of Science ®Google Scholar
• YoumIWestMBLiWDuXEwertDLKopkeRDsiRNA-loaded biodegradable nanocarriers for therapeutic MAPK1 silencing against cisplatin-induced ototoxicityInt J Pharm20175281–261162328627458
   PubMedGoogle Scholar
• KuhadAPilkhwalSSharmaSTirkeyNChopraKEffect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicityJ Agric Food Chem20075525101501015518001039
   PubMed Web of Science ®Google Scholar
• Al MoundhriMSAl-SalamSAl MahrouqeeABeegamSAliBHThe effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: Some behavioral, biochemical, and histopathological studiesJ Med Toxicol201391253322648527
   PubMedGoogle Scholar
• ZhangJLiuJXuXLiLCurcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancerCancer Chemother Pharmacol201779347948728175963
   PubMed Web of Science ®Google Scholar
• HuQSunWWangCGuZRecent advances of cocktail chemotherapy by combination drug delivery systemsAdv Drug Deliv Rev201698193426546751
   PubMed Web of Science ®Google Scholar
• ChengYZhaoPWuSCisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinomaInt J Pharm20185451–226127329730175
   PubMed Web of Science ®Google Scholar
• ZhangYDNanobiotechnologyScience PressBeijing, China2005
   Google Scholar
• MoghimiSMHunterACMurrayJCLongcirculating and target specific nanoparticles: theory to practicePharmacol Rev20015328331811356986
   PubMed Web of Science ®Google Scholar
• PasutGVeroneseFMState of the art in pegylation: the great versatility achieved after forty years of researchJ Control Release2012161246147222094104
   PubMed Web of Science ®Google Scholar
• SukJSXuQKimNHanesJEnsignLMPEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdv Drug Deliv Rev201699285126456916
   PubMed Web of Science ®Google Scholar
• FatmaSTalegaonkarSIqbalZNovel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigationsDrug Deliv201623250051124937381
   PubMed Web of Science ®Google Scholar
• SchmidDJarvisGEFayFNanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicityCell Death Dis2014510e145425299779
   PubMedGoogle Scholar
• XuYWangCDingYNanoparticles with optimal ratiometric co-delivery of docetaxel with gambogic acid for treatment of multidrug-resistant breast cancerJ Biomed Nanotechnol20161291774178129345888
   PubMed Web of Science ®Google Scholar
• JainAKThankiKJainSCo-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicityMol Pharm20131093459347423927416
   PubMed Web of Science ®Google Scholar
• LiuQZhaoDZhuXColoaded nanoparticles of paclitaxel and Piperlongumine for enhancing synergistic antitumor activities and reducing toxicityJ Pharm Sci2017106103066307528552690
   PubMedGoogle Scholar
• KatiyarSSMuntimaduguERafeeqiTADombAJKhanWCo-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatmentDrug Deliv2016232608261626036652
   PubMed Web of Science ®Google Scholar
• ChenYZhengXLFangDLDual agent loaded PLGA nanoparticles enhanced antitumor activity in a multidrug-resistant breast tumor eenograft modelInt J Mol Sci20141522761277224552875
   PubMedGoogle Scholar
• HadinotoKSundaresanACheowWSLipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a reviewEur J Pharm Biopharm2013853 Pt A42744323872180
   PubMed Web of Science ®Google Scholar
• MandalBBhattacharjeeHMittalNCore–shell-type lipid– polymer hybrid nanoparticles as a drug delivery platformNanomedicine20139447449123261500
   PubMed Web of Science ®Google Scholar
• LiCGeXWangLConstruction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: a synergistic combination nanotherapy for cervical cancerBiomed Pharmacother20178662863628027539
   PubMed Web of Science ®Google Scholar
• ZhuBYuLYueQCo-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapyBiomed Pharmacother20179128729428463792
   PubMed Web of Science ®Google Scholar
• RuttalaHBKoYTLiposomal co-delivery of curcumin and albumin/ paclitaxel nanoparticle for enhanced synergistic antitumor efficacyColloids Surf B Biointerfaces201512841942625797481
   PubMed Web of Science ®Google Scholar
• MendesLPGaetiMPde ÁvilaPHMulticompartimental nanoparticles for co-encapsulation and multimodal drug delivery to tumor cells and neovasculaturePharm Res20143151106111924170281
   PubMedGoogle Scholar
• JiangHGengDLiuHLiZCaoJCo-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumorsDrug Deliv20162393665367327749102
   PubMed Web of Science ®Google Scholar
• TangFLiLChenDMesoporous silica nanoparticles: synthesis, bio-compatibility and drug deliveryAdv Mater201224121504153422378538
   PubMed Web of Science ®Google Scholar
• ZhangXGMiaoJDaiYQDuYZYuanHHuF-QReversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cellsInt J Pharm20083611–223924418586075
   PubMed Web of Science ®Google Scholar
• JiaLLiZShenJMultifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistanceInt J Pharm20154891–231833025956050
   PubMed Web of Science ®Google Scholar
• JainAKThankiKJainSSolidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: Part II in vivo pharmacokinetics, antitumor efficacy and hepatotoxicityPharm Res201431494695824135934
   PubMed Web of Science ®Google Scholar
• PemovskaTJohnsonEKontroMAxitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformationNature2015519754110210525686603
   PubMed Web of Science ®Google Scholar
• EscudierBGoreMAxitinib for the management of metastatic renal cell carcinomaDrugs R D201111211312621679004
   PubMedGoogle Scholar
• PangXYiZZhangJCelastrol suppresses angiogenesis-mediated tumor growth through inhibition of Akt/mammalian target of rapamycin pathwayCancer Res20107051951195920160026
   PubMed Web of Science ®Google Scholar
• SethiGAhnKSPandeyMKAggarwalBBA novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activationBlood20071092727273517110449
   PubMed Web of Science ®Google Scholar
• ChoiJYRamasamyTKimSYPEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapyActa Biomater2016399410527163403
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBChitrapriyaNEngineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumorsActa Biomater20174813114327794477
   PubMed Web of Science ®Google Scholar
• ZhangDXuQWangNA complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growthInt J Nanomedicine2018134549456130127606
   PubMed Web of Science ®Google Scholar
• MaWGuoQLiYWangXWangJTuPCo-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacyEur J Pharm Biopharm201711220922327913127
   PubMed Web of Science ®Google Scholar
• GuYLiJLiYNanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancerInt J Nanomedicine2016115757577027843316
   PubMed Web of Science ®Google Scholar
• WangJMaWTuPSynergistically improved anti-tumor efficacy by co-delivery doxorubicin and curcumin polymeric micellesMacromol Biosci20151591252126125981672
   PubMed Web of Science ®Google Scholar
• ShapiraALivneyYDBroxtermanHJAssarafYGNanomedicine for targeted cancer therapy: towards the overcoming of drug resistanceDrug Resist Updat201114315016321330184
   PubMed Web of Science ®Google Scholar
• SreekanthCNBavaSVSreekumarEAntoRJMolecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancerOncogene201130283139315221317920
   PubMed Web of Science ®Google Scholar
• AbouzeidAHPatelNRTorchilinVPPolyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancerInt J Pharm20144641–217818424440402
   PubMedGoogle Scholar
• MengLXiaXYangYCo-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibitionInt J Pharm20165131–281627596118
   PubMedGoogle Scholar
• IshiiKTanakaSKagamiKEffects of naturally occurring polymethyoxyflavonoids on cell growth, P-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cellsCancer Invest201028322022919863351
   PubMed Web of Science ®Google Scholar
• LetchfordKBurtHA review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomesEur J Pharm Biopharm200765325926917196803
   PubMed Web of Science ®Google Scholar
• SinghRLillardJWNanoparticle-based targeted drug deliveryExp Mol Pathol200986321522319186176
   PubMed Web of Science ®Google Scholar
• AlemiAZavar RezaJHaghiralsadatFPaclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacyJ Nanobiotechnol201816128
   PubMed Web of Science ®Google Scholar
• HanCZhangCMaTHypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effectActa Biomater20187726828130006311
   PubMed Web of Science ®Google Scholar
• PereiraSLeeJRubioNCationic Liposome- multi-walled carbon nanotubes hybrids for dual siPLK1 and doxorubicin delivery in vitroPharm Res201532103293330826085038
   PubMedGoogle Scholar
• MartincicMTobiasGFilled carbon nanotubes in biomedical imaging and drug deliveryExpert Opin Drug Deliv201512456358125430876
   PubMed Web of Science ®Google Scholar
• ZhuFTanGJiangYYuZRenFRational design of multi-stimuli-responsive gold nanorod–curcumin conjugates for chemo-photothermal synergistic cancer therapyBiomater Sci20186112905291730209445
   PubMedGoogle Scholar
• LockhartJNStevensDMBeezerDBKravitzAHarthEDual drug delivery of tamoxifen and quercetin: regulated metabolism for anticancer treatment with nanospongesJ Control Release2015220Pt B75175726344396
   PubMedGoogle Scholar
• LiuBHanLLiuJHanSChenZJiangLCo-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancerInt J Nanomedicine20171295596828203075
   PubMed Web of Science ®Google Scholar
• HeCLuKLiuDLinWNanoscale Metal–Organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cellsJ Am Chem Soc2014136145181518424669930
   PubMed Web of Science ®Google Scholar
• YaoXChenLChenXpH-responsive metallo-supramolecular nanogel for synergistic chemo-photodynamic therapyActa Biomater20152516217126190797
   PubMed Web of Science ®Google Scholar
• GasparVMMoreiraAFCostaECGas-generating TPGS-PLGA microspheres loaded with nanoparticles (NIMPS) for co-delivery of minicircle DNA and anti-tumoral drugsColloids Surf B Biointerfaces201513428729426209779
   PubMed Web of Science ®Google Scholar
• WilhelmSTavaresAJDaiQAnalysis of nanoparticle delivery to tumoursNat Rev Mat201615
   Google Scholar
• AlbaneseATangPSChanWCWThe effect of nanoparticle size, shape, and surface chemistry on biological systemsAnnu Rev Biomed Eng201214111622524388
   PubMedGoogle Scholar
• ZhangXQXuXBertrandNPridgenESwamiAFarokhzadOCInteractions of nanomaterials and biological systems: implications to personalized nanomedicineAdv Drug Deliv Rev201264131363138422917779
   PubMed Web of Science ®Google Scholar
• BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
   PubMed Web of Science ®Google Scholar
• GabizonAHorowitzATGorenDTzemachDShmeedaHZalipskySIn vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing miceClin Cancer Res200396551655914695160
   PubMed Web of Science ®Google Scholar
• CalzolariAOlivieroIDeaglioSTransferrin receptor 2 is frequently expressed in human cancer cell linesBlood Cells Mol Dis2007391829117428703
   PubMed Web of Science ®Google Scholar
• CuiTZhangSSunHCo-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatmentOncol Rep20173721253126028075466
   PubMed Web of Science ®Google Scholar
• LowPSAntonyACFolate receptor-targeted drugs for cancer and inflammatory diseasesAdv Drug Deliv Rev20045681055105815094205
   PubMed Web of Science ®Google Scholar
• WangYWangYXiangJYaoKTarget-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticlesBiomacromolecules201011123531353821086982
   PubMedGoogle Scholar
• WangWXiMDuanXWangYKongFDelivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivoInt J Nanomedicine2015103737375026045664
   PubMed Web of Science ®Google Scholar
• FirestoneRALow-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cellsBioconjug Chem1994521051138031872
   PubMed Web of Science ®Google Scholar
• SudhofTGoldsteinJBrownMRussellDThe LDL receptor gene: a mosaic of exons shared with different proteinsScience198522847018158222988123
   PubMed Web of Science ®Google Scholar
• ZhuWJYangSDQuCXLow-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumorInt J Nanomedicine2017123375339328490877
   PubMed Web of Science ®Google Scholar
• YangSDZhuWJZhuQLBinary-copolymer system base on low-density lipoprotein-coupled N-succinyl chitosan lipoic acid micelles for co-delivery MDR1 siRNA and paclitaxel, enhances anti-tumor effects via reducing drugJ Biomed Mater Res2017105511141125
   Google Scholar
• KebebeDLiuYWuYVilakhamxayMLiuZLiJTumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriersInt J Nanomedicine2018131425144229563797
   PubMed Web of Science ®Google Scholar
• NarayananSMonyUVijaykumarDKKoyakuttyMPaul-PrasanthBMenonDSequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cellsNanomedicine20151161399140625888278
   PubMed Web of Science ®Google Scholar
• YanJWangYJiaYCo-delivery of docetaxel and curcumin pro-drug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancerBiomed Pharmacother20178837438328122302
   PubMed Web of Science ®Google Scholar
• WangCSuLWuCWuJZhuCYuanGRGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinomaDrug Dev Ind Pharm201642121938194427142812
   PubMed Web of Science ®Google Scholar
• ZhaoRLiTZhengGJiangKFanLShaoJSimultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplexBiomaterials201714311628755539
   PubMed Web of Science ®Google Scholar
• ShenZWeiWTanakaHA galactosamine-mediated drug delivery carrier for targeted liver cancer therapyPharmacol Res201164441041921723392
   PubMed Web of Science ®Google Scholar
• YanTLiDLiJEffective co-delivery of doxorubicin and curcumin using a glycyrrhetinic acid-modified chitosan-cystamine-poly(ε-caprolactone) copolymer micelle for combination cancer chemotherapyColloids Surf Biointerfaces201614552653827281238
   PubMed Web of Science ®Google Scholar
• TsujiHOsakaSKiwadaHTargeting of liposomes surface-modified with glycyrrhizin to the liver. I. Preparation and biological disopositionChem Pharm Bull1991394100410081893485
   PubMed Web of Science ®Google Scholar
• IshidaSSakiyaYIchikawaTTairaZUptake of glycyrrhizin by isolated rat hepatocytesBiol Pharm Bull19931632932978364475
   PubMed Web of Science ®Google Scholar
• NegishiMIrieANagataNIchikawaASpecific binding of glycyrrhetinic acid to the rat liver membraneBiochim Biophys Acta19911066177822065071
   PubMedGoogle Scholar
• LinALiuYHuangYGlycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted deliveryInt J Pharm20083591–224725318457928
   PubMedGoogle Scholar
• LeeSJZhengNYClavijoMNussenzweigMCNormal host defense during systemic candidiasis in mannose receptor-deficient miceInfect Immun200371143744512496194
   PubMedGoogle Scholar
• HirataKMaruyamaTWatanabeHGenetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeuticsJ Control Release2010145191620304018
   PubMedGoogle Scholar
• ZhangJYuCJiangGSynthesis of cholic-acid-carrying polymer and in-vitro evaluation of hepatoma-targeting nanoparticles decorated with the polymerJ Biomater Sci Polym Ed201627986587927045998
   PubMed Web of Science ®Google Scholar
• ElgoharyMMHelmyMWAbdelfattahE-ZATargeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapyJ Control Release201828523024330009892
   PubMed Web of Science ®Google Scholar
• XiaYXuTWangCNovel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapyInt J Nanomedicine20181314315929317822
   PubMed Web of Science ®Google Scholar
• WanLJiaoJCuiYHyaluronic acid modified mesoporous carbon nanoparticles for targeted drug delivery to CD44-overexpressing cancer cellsNanotechnology2016271313510226901756
   PubMed Web of Science ®Google Scholar
• FengQYuMZWangJCSynergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core–shell nanoparticlesBiomaterials201435185028503824680191
   PubMed Web of Science ®Google Scholar
• ChenJLiSShenQFolic acid and cell-penetrating peptide conjugated PLGA–PEG bifunctional nanoparticles for vincristine sulfate deliveryEur J Pharm Sci201247243044322796217
   PubMed Web of Science ®Google Scholar
• GaoZYouCWuHWangMZhangXSunBFA and cRGD dual modified lipid-polymer nanoparticles encapsulating polyaniline and cisplatin for highly effective chemo-photothermal combination therapyJ Biomater Sci Polym Ed201829439741129271285
   PubMed Web of Science ®Google Scholar
• ZhangJLiJShiZpH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activitiesActa Biomater20175834936428455219
   PubMed Web of Science ®Google Scholar
• DanafarHSharafiAKheiriSKheiri ManjiliHCo-delivery of sulforaphane and curcumin with pegylated iron Oxide-Gold core shell nanoparticles for delivery to breast cancer cell lineIran J Pharm Res201817248049429881406
   PubMed Web of Science ®Google Scholar
• ChangJEChoHJYiEKimDDJheonSHypocrellin B and paclitaxel-encapsulated hyaluronic acid-ceramide nanoparticles for targeted photodynamic therapy in lung cancerJ Photochem Photobiol B201615811312126967521
   PubMed Web of Science ®Google Scholar
• YinYHuQXuCCo-delivery of doxorubicin and interferon-γ by thermosensitive nanoparticles for cancer immunochemotherapyMol Pharm20181594161417230011369
   PubMed Web of Science ®Google Scholar
• YinTWangLYinLZhouJHuoMCo-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancerBiomaterials201561102525996409
   PubMed Web of Science ®Google Scholar